ULURU TO PRESENT CLINICAL EVIDENCE AND ADVANCED RESEARCH ON ALTRAZEAL AT THE SOCIETY FOR ADVANCE WOUND CARE CONFERENCE FOR 2009
Addison, Texas, April 23, 2009; ULURU Inc. (NYSE AMEX: ULU) announced today that clinical evidence on the treatment of wounds using Altrazeal™ along with pre-clinical and physical data on Altrazeal™ and Altrazeal™ Silver will be presented at the annual Society for Advance Wound Care Conference (“SAWC”) being held in Grapevine, Texas, April 26-30, 2009. The clinical evidence and data will be presented on posters on display during the meeting.
Read More